Cantor Fitzgerald lowered the firm’s price target on BXP (BXP) to $70 from $79 and keeps an Overweight rating on the shares. Boston Properties faces a slower-than-expected “flight-to-quality” demand shift despite strong AI-driven leasing activity and improving life sciences demand in Boston/Cambridge, with elevated near-term capex and transaction timing effects weighing on near-term results even as occupancy gains toward 91% and asset-level monetization efforts support a longer-term positive outlook, the analyst tells investors in a research note.
